OptiBiotix Health PLC (OPTBF)
OptiBiotix Health PLC operates in the Biotechnology industry of the Healthcare sector, headquartered in York, GB. The stock last traded at $0.11, up 0.00% on the session, giving a market capitalisation of $11.4M. On trailing twelve-month figures it carries a trailing P/E of -1.41, a net margin of -332.7%. Its beta of 1.82 implies it has historically moved more than the broad market.
OptiBiotix Health plc is a life sciences company that develops compounds to modify the human microbiome to prevent and manage human disease. The company's portfolio includes products that aim to reduce hunger and food cravings and enhance the gut microbiome. OptiBiotix has developed microbiome-based ingredients and products such as SlimBiome®, WellBiome®, and SweetBiotix®, and has agreements with numerous international food and healthcare supplement companies to incorporate these into various products.
OptiBiotix Health PLC is most often compared with the following Healthcare names: